AI-designed drug shows early signs of reversing biological age

Insilico Medicine announced that Rentosertib, a candidate drug whose molecular structure was designed with generative AI, showed signs of delaying or even reversing aging in a small clinical trial. The study was published in Nature Biotechnology and covered by New York Times reporter Cade Metz.

Confirmed

Rentosertib is an AI-assisted antifibrotic candidate originally targeting a rare lung disease (chronic lung disease); this trial involved 42 patients in a small clinical trial, evaluated after 12 weeks of treatment
Proteomics analysis showed that all six "aging clocks" (run by six independent teams) predicted biological age shifts toward being younger by roughly 3-4 years in the treatment group, while the placebo group changed little or rose slightly
The results were published in Nature Biotechnology

Not Yet Confirmed

Eric Topol noted the results would be especially striking if validated in larger, independent studies, but remain early data
A causal link between aging clock reversal and actually slowing aging has not been established

Why It Matters

This is the first time an AI-designed drug has shown this kind of human signal in anti-aging; if validated, it would expand the indication boundaries of AI-driven drug discovery
Researcher @DrBischof said that these methods stratified by organ clocks and drug dosage "will be used in future clinical trials," potentially influencing subsequent trial design paradigms

2026-09-07 ~ 2026-09-07 · 7 related posts

Primary sources

AI-designed drug rentosertib slowed 6 of 6 proteomic aging clocks in trial — EricTopol · 2026-09-07 22:02 (UTC+08:00)
AI-developed drug rentosertib shows early anti-aging signals across six aging clocks — Dr_Singularity · 2026-09-07 23:23 (UTC+08:00)
Eric Topol hails AI trial methods covered by NYT: "exciting if confirmed" — EricTopol · 2026-09-07 22:05 (UTC+08:00)

[source] AI-designed drug rentosertib slowed 6 of 6 proteomic aging clocks in trial — EricTopol · 2026-09-07
[source] Eric Topol hails AI trial methods covered by NYT: "exciting if confirmed" — EricTopol · 2026-09-07
Early data suggests an AI-developed drug could slow aging — Dr_Singularity · 2026-09-07
[source] AI-developed drug rentosertib shows early anti-aging signals across six aging clocks — Dr_Singularity · 2026-09-07

3 near-duplicate retellings: coherence · AllThingsApx · Dr_Singularity